MRK Keytruda is now the world´s largest drug (by $)
$Merck(MRK)$ Keytruda is now the world´s largest drug (by $)
$25 B sales in FY23
42% of Merck revenue
Loses exclusivity in 2028
Some resemblance to $AbbVie(ABBV)$ and Humira weight
Image
ABBV Humira
Peaked at 58% of revenue
37% just before Loss of exclusivity (acquisition in between reduced the weight - most notably Allergan 2Q'20)
Image
MRK goes ex-dividend tomorrow MAR14
2.5% dividend yield
6% CAGR dividend growth
56% FCF payout
Image
https://twitter.com/DividendWave/status/1767983993675198812
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
